These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6418572)

  • 1. The functional domain of hirudin, a thrombin-specific inhibitor.
    Chang JY
    FEBS Lett; 1983 Dec; 164(2):307-13. PubMed ID: 6418572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA.
    Dodt J; Machleidt W; Seemüller U; Maschler R; Fritz H
    Biol Chem Hoppe Seyler; 1986 Aug; 367(8):803-11. PubMed ID: 3768144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
    Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
    Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech.
    Mao SJ; Yates MT; Blankenship DT; Cardin AD; Krstenansky JL; Lovenberg W; Jackson RL
    Anal Biochem; 1987 Mar; 161(2):514-8. PubMed ID: 3578808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8-A resolution.
    Vitali J; Martin PD; Malkowski MG; Robertson WD; Lazar JB; Winant RC; Johnson PH; Edwards BF
    J Biol Chem; 1992 Sep; 267(25):17670-8. PubMed ID: 1517214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative properties of hirudin from whole leeches and from leech heads and bodies].
    Baskova IP; Cherkesova DU
    Biokhimiia; 1980 Feb; 45(2):267-72. PubMed ID: 7388067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the N-terminal region of hirudin to its interaction with thrombin.
    Wallace A; Dennis S; Hofsteenge J; Stone SR
    Biochemistry; 1989 Dec; 28(26):10079-84. PubMed ID: 2620063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
    Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
    FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65.
    Krstenansky JL; Mao SJ
    FEBS Lett; 1987 Jan; 211(1):10-6. PubMed ID: 3803584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
    Mao SJ; Yates MT; Owen TJ; Krstenansky JL
    Biochemistry; 1988 Oct; 27(21):8170-3. PubMed ID: 3233202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin activity of the hirudin N-terminal core domain residues 1-43.
    Chang JY; Schlaeppi JM; Stone SR
    FEBS Lett; 1990 Jan; 260(2):209-12. PubMed ID: 2404798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
    Koch C; Whitechurch O; Cordier P; Roitsch C
    Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides.
    Krstenansky JL; Owen TJ; Yates MT; Mao SJ
    FEBS Lett; 1990 Sep; 269(2):425-9. PubMed ID: 2401369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of noncoded amino acids into the N-terminal domain 1-47 of hirudin yields a highly potent and selective thrombin inhibitor.
    De Filippis V; Russo I; Vindigni A; Di Cera E; Salmaso S; Fontana A
    Protein Sci; 1999 Oct; 8(10):2213-7. PubMed ID: 10548068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.